EUVIMEDEUVIMED entdecken
Crossref

Chitosan- g -estrone Nanoparticles of Palbociclib Vanished Hypoxic Breast Tumor after Targeted Delivery: Development and Ultrasound/Photoacoustic Imaging

Abhishesh Kumar Mehata, Virendra Singh, Vikas, Nitesh Singh, Abhijit Mandal, Debabrata Dash, Biplob Koch iD, Madaswamy S Muthu iD

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c03184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Abhishesh Kumar Mehata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, (BHU), Varanasi 221005, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Chitosan, Photoacoustic Techniques, Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Indian Institute of Technology (BHU) Varanasi, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the leading cause of death among women globally. Approximately 80% of all breast cancers diagnosed are overexpressed with estrogen receptors (ERs). In this study, we have developed an estrone (Egen)-grafted chitosan-based polymeric nanocarrier for the targeted delivery of palbociclib (PLB) to breast cancer. The nanoparticles (NPs) were prepared by solvent evaporation using the ionic gelation method and characterized for particle size, zeta potential, polydispersity, surface morphology, surface chemistry, drug entrapment efficiency, cytotoxicity assay, cellular uptake, and apoptosis study. The developed PLB-CS NPs and PLB-CS-g-Egen NPs had a particle size of 116.3 ± 1.53 nm and 141.6 ± 1.97 nm, respectively. The zeta potential of PLB-CS NPs and PLB-CS-g-Egen NPs was found to be 18.70 ± 0.416 mV and 12.45 ± 0.574 mV, respectively. The morphological analysis demonstrated that all NPs were spherical in shape and had a smooth surface. An in vitro cytotoxicity assay was performed in estrogen receptor (ER)-expressing MCF7 cells and T47D cells, which suggested that targeted NPs were 57.34- and 30.32-fold more cytotoxic compared to the pure PLB, respectively. Additionally, cell cycle analysis confirmed that cell cycle progression from the G1 into S phase was blocked more efficiently by targeted NPs compared to nontargeted NPs and PLB in MCF7 cells. In vivo pharmacokinetic studies demonstrated that entrapment of the PLB in the NPs improved the half-life and bioavailability by ∼2-3-fold. Further, ultrasound and photoacoustic imaging of DMBA induced breast cancer in the Sprague-Dawley (SD) rat showed that targeted NPs completely vanished breast tumor, reduced hypoxic tumor volume, and suppressed tumor angiogenesis more efficiently compared to the nontargeted NPs and free PLB. Further, in vitro hemocompatibility and histopathology studies suggested that NPs were biocompatible and safe for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanPhotoacoustic TechniquesNanoparticlesRatsAnimalsFemaleEstroneDrug CarriersRats, Sprague-DawleyParticle SizePiperazinesPyridines

Stichwörter der Autor:innen

breast tumorestrogen receptor targeted drug deliveryin vivo imagingpalbociclibultrasound and photoacoustic imaging

Substanzen

EstroneChitosanDrug CarrierspalbociclibPiperazinesPyridines

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, (BHU), Varanasi 221005, Uttar Pradesh, India.
  • Cancer Biology Laboratory, Department of Zoology Institute of Science, (BHU), Varanasi 221005, Uttar Pradesh, India.
  • Department of Biochemistry, Institute of Medical Sciences, (BHU), Varanasi 221005, Uttar Pradesh, India.
  • Department of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, (BHU), Varanasi 221005, Uttar Pradesh, India.

ORCID-Profile: Biplob Koch, Madaswamy S Muthu

Förderung

  • Indian Institute of Technology (BHU) Varanasi
  • Ministry of Education, India

Zitieren

APA

Mehata, A. K., Singh, V., Vikas, Singh, N., Mandal, A., Dash, D., Koch, B., & Muthu, M. S. (2023). Chitosan- g -estrone Nanoparticles of Palbociclib Vanished Hypoxic Breast Tumor after Targeted Delivery: Development and Ultrasound/Photoacoustic Imaging. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c03184

Vancouver

Mehata AK, Singh V, Vikas, Singh N, Mandal A, Dash D, et al. Chitosan- g -estrone Nanoparticles of Palbociclib Vanished Hypoxic Breast Tumor after Targeted Delivery: Development and Ultrasound/Photoacoustic Imaging. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c03184

BibTeX
@article{Mehata2023,
  author = {Mehata, Abhishesh Kumar and Singh, Virendra and Vikas and Singh, Nitesh and Mandal, Abhijit and Dash, Debabrata and Koch, Biplob and Muthu, Madaswamy S},
  title = {Chitosan- g -estrone Nanoparticles of Palbociclib Vanished Hypoxic Breast Tumor after Targeted Delivery: Development and Ultrasound/Photoacoustic Imaging},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c03184}
}
Kostenlos starten →